MedTech News
.................... by Andrew Celentano
Travere’s Filspari overcomes Phase 3 fail to become first drug for rare kidney disease
The FDA has greenlit Travere Therapeutics’ Filspari as the only available treatment for focal segmental glomerulosclerosis despite the drug’s loss to Sanofi’s Avapro in a Phase 3 study.
New drug doubles one-year survival in pancreatic cancer trial
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
Protaryx earns FDA nod for transseptal puncture device
Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.
Smart OLED patch uses light to automate drug delivery, doubling healing speed
A research team has developed a “self-regulating OLED wound healing patch” that combines light and drugs to pull up the wound recovery speed by about twice.
Simple procedure relieves painful complications after deep vein thrombosis
A major multi-site clinical trial co-led by researchers at Washington University School of Medicine in St. Louis has shown that post-thrombotic syndrome—a common and often painful complication suffered by many people who have experienced blockages of major veins due to blood clots—can be effectively treated with a minimally invasive procedure.
Low-frequency wireless sensor tracks artery stiffening in real time with less interference
A Korean research team has developed a low-frequency-based wireless sensor technology.
ProSomnus gets FDA nod for latest sleep apnea therapy device
ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
Beckman Coulter obtains CE mark for bacterial-viral differentiator test
Used with Beckman’s immunoassay analysers, MeMed’s BV test has been demonstrated to reduce unnecessary antibiotic use.